Clinical Trials
8 trialsNCT07237594 2026-03-11
REPLAY
Duke University
Phase 1 Not yet recruiting
NCT06833112 2025-02-18
Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis
The Affiliated Hospital Of Guizhou Medical University
Phase 4 Not yet recruiting
NCT04571567 2022-04-11
A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis
Icahn School of Medicine at Mount Sinai
Phase 4 Completed
NCT04298320 2020-03-16
A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457）
Harbin Medical University
Phase 1/2 Unknown
NCT01961609 2019-03-18
SIGNATURE
Novartis
Phase 3 Completed
NCT02911857 2018-08-20
An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
Novartis
Phase 3 Completed
NCT01350804 2016-05-23
NURTURE 1
Novartis
Phase 3 Completed
NCT00584740 2015-03-31
Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease
Novartis
Phase 2 Terminated